Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 18, 2026 | MagVenture Announces FDA Clearance of Wave Neuroscience's MeRT® System for PTSD, delivered on MagVenture® Technology | Patient receiving MagVenture TMS therapy via MeRT for PTSD treatment. Wave’s FDA clearance of MeRT® for PTSD marks an important advancement for patients whose lives have been shaped by trauma, including veterans, first responders, and many ... |
| May 26, 2026 | MagVenture Receives FDA Clearance for Accelerated TMS Protocols, Expanding Flexibility for Clinics and Patients | Providers and patients enjoy flexibility with MagVenture Accelerated TMS ALPHARETTA, GA, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- MagVenture®, a global leader in non-invasive neuromodulation technology, today announced that the U.S... |
| May 13, 2026 | MagVenture Launches MagVenture Go™ Portable TMS System to Enhance Clinical Flexibility | MagVenture Go Portable TMS ALPHARETTA, GA, UNITED STATES, May 13, 2026 /EINPresswire.com/ -- MagVenture, a global leader in non-invasive neuromodulation technology, today announced the launch of the MagVenture Go™ Portable TMS system, a com... |
| Sep 2, 2025 | FDA Expands MagVenture TMS Indications to Treat MDD, OCD, and Anxious Depression with One Coil | MagVenture TMS Therapy for depression With this expanded portfolio, our users can now choose the most appropriate coil for each specific patient, prioritizing comfort, treatment precision, and outcomes.” — Kerry Rome, SVP MagVenture, Inc.AL... |
| Aug 25, 2025 | MagVenture Receives FDA Clearance to Expand TMS Therapy Indication for Adolescents Aged 15–21 | MagVenture TMS Therapy for depression ALPHARETTA, GA, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- MagVenture, the global leader of non-invasive TMS neuromodulation technology, announced today that the U.S. Food and Drug Administrat... |
| May 1, 2024 | MagVenture Announces Collaboration with Magnus Medical to Bring the SAINT® Neuromodulation System to Market | |
| Mar 28, 2023 | FDA Clears MagVenture TMS Atlas™ Neuro Navigation System for High-Precision, Personalized TMS Coil Positioning in the US | MagVenture TMS Therapy System with Atlas Neuro Navigation MagVenture Atlas pulse electromagnetic transmitter Atlas Neuro Navigation patient reference sensors, coil sensor, and pointer ALPHARETTA, GEORGIA, USA, March 28, 2023/EINPresswire.co... |
| Sep 16, 2022 | Cigna extends coverage for Brainsway’s brain stimulation device to treat OCD | Obsessive-Compulsive Disorder (OCD) has been ranked by the World Health Organization as one of the top 10 most debilitating medical conditions in terms of loss of income and decreased quality of life. The condition is a complex one that pre... |
Reviews 0
FAQ about MagVenture
What has the press written about MagVenture?
Parsers VC has collected 9 articles mentioning MagVenture, among them “MagVenture Announces FDA Clearance of Wave Neuroscience's MeRT® System for PTSD, delivered on MagVenture® Technology” (Jun 18, 2026) and “MagVenture Receives FDA Clearance for Accelerated TMS Protocols, Expanding Flexibility for Clinics and Patients” (May 26, 2026).
Is MagVenture still active?
Yes, MagVenture is active; its latest activity on Parsers VC dates from Oct 13, 2026.